A new insulin dosing system for type 2 diabetes gets FDA nod


eMediNexus    20 February 2018

The US Food and Drug Administration has approved the Glooko Mobile Insulin Dosing System for the titration of long-acting (basal) insulin for people with type 2 diabetes.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.